Cardiovascular Diseases

Category: HIC#14530
Title:
A Phase III, Double-blind, Randomized Placebo-controlled Study, to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in Stable CHD Patients, With a Documented Recent Acute Coronary Syndrome (ACS)
Primary Investigator: Gimple Lawrence, W
Department: Internal Medicine
Division: Cardiovascular Medicine (Heart Center) 		Accepts adult enrollment :YES
Accepts minor enrollment :NO